178 related articles for article (PubMed ID: 24143196)
1. Association of 5-methylcytosine and 5-hydroxymethylcytosine with mitochondrial DNA content and clinical and biochemical parameters in hepatocellular carcinoma.
Shen F; Huang W; Qi JH; Yuan BF; Huang JT; Zhou X; Feng YQ; Liu YJ; Liu SM
PLoS One; 2013; 8(10):e76967. PubMed ID: 24143196
[TBL] [Abstract][Full Text] [Related]
2. Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1.
Liu C; Liu L; Chen X; Shen J; Shan J; Xu Y; Yang Z; Wu L; Xia F; Bie P; Cui Y; Bian XW; Qian C
PLoS One; 2013; 8(5):e62828. PubMed ID: 23671639
[TBL] [Abstract][Full Text] [Related]
3. Quantification of 5-methylcytosine and 5-hydroxymethylcytosine in genomic DNA from hepatocellular carcinoma tissues by capillary hydrophilic-interaction liquid chromatography/quadrupole TOF mass spectrometry.
Chen ML; Shen F; Huang W; Qi JH; Wang Y; Feng YQ; Liu SM; Yuan BF
Clin Chem; 2013 May; 59(5):824-32. PubMed ID: 23344498
[TBL] [Abstract][Full Text] [Related]
4. Whole-genome DNA methylation and hydroxymethylation profiling for HBV-related hepatocellular carcinoma.
Ye C; Tao R; Cao Q; Zhu D; Wang Y; Wang J; Lu J; Chen E; Li L
Int J Oncol; 2016 Aug; 49(2):589-602. PubMed ID: 27221337
[TBL] [Abstract][Full Text] [Related]
5. Decrease of 5-hydroxymethylcytosine in hepatitis B virus-related hepatocellular carcinoma: A cross-sectional study.
Jia Y; Liu Z; Dai M; Feng J; Ye L; Zhang H; Dai E
Medicine (Baltimore); 2023 Jun; 102(22):e33943. PubMed ID: 37266610
[TBL] [Abstract][Full Text] [Related]
6. Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis.
Guo XJ; Huang XY; Yang X; Lu JC; Wei CY; Gao C; Pei YZ; Chen Y; Sun QM; Cai JB; Zhou J; Fan J; Ke AW; Shi YG; Shen YH; Zhang PF; Shi GM; Yang GH
Cell Death Dis; 2023 Feb; 14(2):79. PubMed ID: 36732324
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial DNA Copy Number in Egyptian Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma.
Hashad DI; Elyamany AS; Salem PE
Genet Test Mol Biomarkers; 2015 Nov; 19(11):604-9. PubMed ID: 26447820
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide hypomethylation in hepatocellular carcinogenesis.
Lin CH; Hsieh SY; Sheen IS; Lee WC; Chen TC; Shyu WC; Liaw YF
Cancer Res; 2001 May; 61(10):4238-43. PubMed ID: 11358850
[TBL] [Abstract][Full Text] [Related]
9. Role of ten-eleven translocation proteins and 5-hydroxymethylcytosine in hepatocellular carcinoma.
Wang P; Yan Y; Yu W; Zhang H
Cell Prolif; 2019 Jul; 52(4):e12626. PubMed ID: 31033072
[TBL] [Abstract][Full Text] [Related]
10. Association of mitochondrial DNA content in peripheral blood leukocyte with hepatitis B virus-related hepatocellular carcinoma in a Chinese Han population.
Zhao S; Yang Y; Liu J; Liu H; Ge N; Yang H; Zhang H; Xing J
Cancer Sci; 2011 Aug; 102(8):1553-8. PubMed ID: 21521418
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axis.
Chen Q; Yin D; Zhang Y; Yu L; Li XD; Zhou ZJ; Zhou SL; Gao DM; Hu J; Jin C; Wang Z; Shi YH; Cao Y; Fan J; Dai Z; Zhou J
Cell Death Dis; 2017 Jun; 8(6):e2906. PubMed ID: 28661477
[TBL] [Abstract][Full Text] [Related]
12. High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma.
Liu WR; Tian MX; Jin L; Yang LX; Ding ZB; Shen YH; Peng YF; Zhou J; Qiu SJ; Dai Z; Fan J; Shi YH
J Exp Clin Cancer Res; 2014 Apr; 33(1):32. PubMed ID: 24716838
[TBL] [Abstract][Full Text] [Related]
13. Effect of valproic acid on mitochondrial epigenetics.
Chen H; Dzitoyeva S; Manev H
Eur J Pharmacol; 2012 Sep; 690(1-3):51-9. PubMed ID: 22728245
[TBL] [Abstract][Full Text] [Related]
14. Distinct global DNA methylation status in B-cell lymphomas: immunohistochemical study of 5-methylcytosine and 5-hydroxymethylcytosine.
Matsuda I; Imai Y; Hirota S
J Clin Exp Hematop; 2014; 54(1):67-73. PubMed ID: 24942948
[TBL] [Abstract][Full Text] [Related]
15. Hydroxymethylcytosine and demethylation of the γ-globin gene promoter during erythroid differentiation.
Ruiz MA; Rivers A; Ibanez V; Vaitkus K; Mahmud N; DeSimone J; Lavelle D
Epigenetics; 2015; 10(5):397-407. PubMed ID: 25932923
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma.
Hsu CC; Lee HC; Wei YH
World J Gastroenterol; 2013 Dec; 19(47):8880-6. PubMed ID: 24379611
[TBL] [Abstract][Full Text] [Related]
17. New themes in the biological functions of 5-methylcytosine and 5-hydroxymethylcytosine.
Moen EL; Mariani CJ; Zullow H; Jeff-Eke M; Litwin E; Nikitas JN; Godley LA
Immunol Rev; 2015 Jan; 263(1):36-49. PubMed ID: 25510270
[TBL] [Abstract][Full Text] [Related]
18. Lymphocytic mitochondrial DNA deletions, biochemical folate status and hepatocellular carcinoma susceptibility in a case-control study.
Wu MY; Kuo CS; Lin CY; Lu CL; Syu Huang RF
Br J Nutr; 2009 Sep; 102(5):715-21. PubMed ID: 19331700
[TBL] [Abstract][Full Text] [Related]
19. Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype.
Tsai KW; Li GC; Chen CH; Yeh MH; Huang JS; Tseng HH; Fu TY; Liou HH; Pan HW; Huang SF; Chen CC; Chang HY; Ger LP; Chang HT
Breast Cancer Res Treat; 2015 Aug; 153(1):219-34. PubMed ID: 26253945
[TBL] [Abstract][Full Text] [Related]
20. Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma.
Yamada S; Nomoto S; Fujii T; Kaneko T; Takeda S; Inoue S; Kanazumi N; Nakao A
Eur J Surg Oncol; 2006 Apr; 32(3):303-7. PubMed ID: 16478656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
